United States· US:10742-8160_2978fba5-0be6-3179-e063-6294a90a182a
Rohto Optic Glow
A sympathomimetics, plain product containing naphazoline hydrochloride, povidone, propylene glycol, registered in United States by The Mentholatum Company. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Naphazoline hydrochloride, povidone, propylene glycol is registered in 2 of 19 countries.
Countries holding a registration under ATC R01AA (sympathomimetics, plain), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Naphazoline hydrochloride, povidone, propylene glycol · ATC R01AA
2 / 19 countries
- Belgiumprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Naphazoline hydrochloride, Povidone, Propylene glycol
- Manufacturer
- The Mentholatum Company
- Country
- United States (US)
- ATC code
- R01AA
- ATC class
- Sympathomimetics, plain
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1110742816011 BOTTLE, WITH APPLICATOR in 1 CARTON (10742-8160-1) / 13 mL in 1 BOTTLE, WITH APPLICATOR
Regulatory notes
Same class
Other records under R01AA
Sympathomimetics, plain, as other registers publish it.
- United StatesGNP Eye Drops Seasonal ReliefAmerisourceBergen
- United StatesGood Neighbor Pharmacy Eye DropsAmerisourceBergen Drug Corporation
- United StatesRohtoThe Mentholatum Company
- United StatesRohtoThe Mentholatum Company
- United StatesRohtoThe Mentholatum Company
- BelgiumVasocedine Naphazoline 0.1 %Laboratoria Qualiphar
- BelgiumVasocedine Naphazoline 0.1 %Laboratoria Qualiphar
- United StatesVisine Red Eye Total Comfort Multi-SymptomKenvue Brands LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf3adebd-b906-4778-a2b7-b199a11eddc0 GET /v1/drugs/bf3adebd-b906-4778-a2b7-b199a11eddc0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "MZ1131787D",
"rxcui": "82054",
"inchikey": "DJDFFEBSKJCGHC-UHFFFAOYSA-N",
"display_name": "NAPHAZOLINE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "OPHTHALMIC",
"spl_meta": {
"1b597f83-d7f1-cf93-e063-6394a90a99f7": {
"match": "brand_token",
"title": "ROHTO DUAL LIGHT RELIEF (HYPROMELLOSE, POVIDONE) LIQUID [THE MENTHOLATUM COMPANY]",
"spl_version": "3",
"published_date": "2024-12-23"
}
},
"productid": "10742-8160_2978fba5-0be6-3179-e063-6294a90a182a",
"productndc": "10742-8160",
"dosage_form": "LIQUID",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "NAPHAZOLINE HYDROCHLORIDE; POVIDONE, UNSPECIFIED; PROPYLENE GLYCOL",
"proprietary_name": "Rohto Optic Glow",
"active_ingred_unit": "mg/mL; mg/mL; mg/mL",
"application_number": "M018",
"marketing_category": "OTC MONOGRAPH DRUG",
"nonproprietary_name": "Naphazoline hydrochloride, Povidone, Propylene glycol",
"start_marketing_date": "20210326",
"active_numerator_strength": ".3; 5; 2"
}See everything about naphazoline hydrochloride, povidone, propylene glycol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.